MedTrace Logo

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

NCT00679640 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2010-12-02

No results posted yet for this study

Summary

The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution

Conditions

Interventions

DRUG

Candesartan

Oral tablets

Sponsors & Collaborators

Principal Investigators

  • Stephane Bouee, MD, MSc · CEMKA EVAL - Bourg La Reine - France

  • Luc Hittinger, MD, Prof · Hôpital Henri Mondor - Service de cardiologie - Créteil - France

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-06-30
Completion
2010-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00679640 on ClinicalTrials.gov